Murakami Daisuke, Miyashita Kaname, Koyama Tetsuya, Omori Hirofumi, Miyamoto Yusuke, Sawatsubashi Motohiro, Nakagawa Takashi
J Clin Exp Hematop. 2019 Sep 30;59(3):101-107. doi: 10.3960/jslrt.18008. Epub 2019 Aug 8.
The present study investigated histological subtypes of lymphoma in patients newly diagnosed with malignant lymphoma in the human T-cell leukemia virus type 1 (HTLV-1) endemic area of Japan, and further analyzed the clinicopathological features and clinical outcomes of patients with primary sinonasal lymphoma. We retrospectively examined 151 patients aged 18-90 years in Fukuoka, Japan. Subtypes of lymphoma were determined according to the WHO classification. Among the 151 patients, 104 were diagnosed with malignant lymphoma, including 96 at the time of initial diagnosis. Ninety-two of the 96 lymphomas (96%) were non-Hodgkin lymphoma. Mature B-cell neoplasms comprised 78% (n = 75). Primary lymphoma of the sinonasal cavity was found in six patients (6%). The histological subtype of sinonasal lymphoma was diffuse large B-cell lymphoma (DLBCL) in all six tumors. Furthermore, overall survival was significantly different among three distinct DLBCL patient groups, including primary sinonasal lymphoma patients (p = 0.0016; 3-year overall survival: sinonasal DLBCL group, 53%; DLBCL of the CNS group, 0%; other DLBCL group, 83%). Our study suggests that primary DLBCL of the sinonasal tract is a distinct disease entity of DLBCL.
本研究调查了日本人类T细胞白血病病毒1型(HTLV-1)流行地区新诊断为恶性淋巴瘤患者的淋巴瘤组织学亚型,并进一步分析了原发性鼻窦淋巴瘤患者的临床病理特征和临床结局。我们回顾性研究了日本福冈151例年龄在18至90岁之间的患者。淋巴瘤亚型根据世界卫生组织分类确定。在这151例患者中,104例被诊断为恶性淋巴瘤,其中96例为初诊时确诊。96例淋巴瘤中有92例(96%)为非霍奇金淋巴瘤。成熟B细胞肿瘤占78%(n = 75)。鼻窦原发性淋巴瘤在6例患者中发现(6%)。所有6例肿瘤的鼻窦淋巴瘤组织学亚型均为弥漫性大B细胞淋巴瘤(DLBCL)。此外,在包括原发性鼻窦淋巴瘤患者在内的三个不同DLBCL患者组中,总生存期有显著差异(p = 0.0016;3年总生存期:鼻窦DLBCL组为53%;中枢神经系统DLBCL组为0%;其他DLBCL组为83%)。我们的研究表明,鼻窦原发性DLBCL是DLBCL的一种独特疾病实体。